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Introduction
To  preserve  epithelial  barrier  function  during  cell  turnover,   
dying cells are shoved out of the epithelium by a process we 
have termed “apoptotic cell extrusion” (Rosenblatt et al., 2001). 
Here, the cell destined for apoptosis signals its live neighbor-
ing epithelial cells to form a ring of actin and myosin II that 
contracts to squeeze the dying cell out of the epithelial sheet. 
This contraction not only ejects the dying cell out of the layer 
but also closes any gaps that may have resulted from the dying 
cell’s exit.
Importantly, cells can be extruded either apically into the 
lumen or basally back into the tissue the epithelia encases. 
Previously, we only detected apical extrusion of apoptotic 
cells from the epithelia encasing vertebrate embryos and adult   
organs. However, we find that basal extrusion occurs occasion-
ally in vertebrates and commonly in Drosophila embryonic epi-
thelia (also see Gibson and Perrimon, 2005; Vidal et al., 2006; 
Ninov et al., 2007). The direction a cell is extruded is important 
for  its  fate,  as  corpses  extruded  basally  must  be  engulfed, 
whereas those extruded apically may be expelled or trapped in 
the lumen. Extrusion direction is likely more important in cases 
where cells are blocked from death but still extrude. Apical 
extrusion  would  still  eliminate  these  cells,  whereas  basal   
extrusion could allow live cells to be retained in the tissue to 
potentially migrate elsewhere. Because this decision is critical 
for the extruded cell’s fate, we sought to identify the molecular 
mechanism that determines the direction a cell will extrude.
Although our previous work had established the fact that 
apoptotic cell extrusion requires Rho-mediated contraction of 
an intercellular actin/myosin II ring in the cells surrounding the 
dying cell (Rosenblatt et al., 2001), we did not examine how 
actin/myosin contraction is organized to squeeze the dying cell 
out apically into the lumen. Further, we did not notice the minor 
populations of apoptotic cells that extruded basally in tissue 
culture monolayers. Here, we analyze how actin and myosin 
contraction is regulated differently when cells extrude apically 
versus basally using cultured epithelial monolayers from canine 
kidney, MDCK, or human bronchia (16-HBE-14o), as well as 
the epidermis of live zebrafish. We find that apical extrusion   
requires reorientation of microtubules and associated p115   
RhoGEF basolaterally, which activates Rho to contract actin/
myosin basally and squeeze the dying cell out.
T
o preserve epithelial barrier function, dying cells 
are squeezed out of an epithelium by “apoptotic 
cell  extrusion.”  Specifically,  a  cell  destined  for 
apoptosis signals its live neighboring epithelial cells to 
form and contract a ring of actin and myosin II that 
squeezes  the  dying  cell  out  of  the  epithelial  sheet.   
Although most apoptotic cells extrude apically, we find 
that some exit basally. Localization of actin and myosin 
IIA contraction dictates the extrusion direction: basal 
extrusion requires circumferential contraction of neigh-
boring cells at their apices, whereas apical extrusion 
also requires downward contraction along the baso-
lateral surfaces. To activate actin/myosin basolaterally, 
microtubules in neighboring cells reorient and target 
p115 RhoGEF to this site. Preventing microtubule re-
orientation  restricts  contraction  to  the  apex,  driving   
extrusion basally. Extrusion polarity has important impli-
cations for tumors where apoptosis is blocked but extru-
sion is not, as basal extrusion could enable these cells 
to initiate metastasis.
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that epithelial polarity is not markedly altered when cells ex-
trude basally versus apically.
To examine where actin/myosin contraction occurred, we 
immunostained extruding monolayers with a phospho-myosin 
II antibody that recognizes only actively contracting myosin II 
(Matsumura et al., 1998). We find that myosin IIA contraction 
is active along the basolateral interface between the apoptotic 
cell and its neighboring cells during apical extrusion but is   
restricted to the apical interface during basal extrusion (Figs. 2 c  
and  S1,  control).  Localization  of  phospho-myosin  II  and   
videos of extrusion suggest that all extrusion events require co-
ordinated, circumferential contraction of the cortical actin and 
myosin II at the cell–cell contacts that interface with the dying 
cell. The difference in whether extrusion occurs apically rather 
than basally appears to be linked to whether basolateral contrac-
tion also occurs at this ring.
If  extrusion  direction  corresponds  to  where  myosin 
II assembles and contracts, what controls its localization? 
Because  microtubules  have  been  found  to  activate  or  in-
hibit myosin II contraction in cytokinesis and other con-
tractile  processes  (Wittmann  and  Waterman-Storer,  2001;   
Matsumura, 2005), we examined whether microtubules regu-
late myosin II contraction during extrusion. Live 3D videos 
of mApple-actin and GFP-tubulin show that microtubules 
dynamically reorient toward the actin-extruding ring early 
and  throughout  extrusion  process,  but  retract  once  extru-
sion is complete during both apical and basal extrusion (see   
Videos 8 and 9, respectively). Because microtubules grow 
dynamically  toward  the  ring,  we  reasoned  that  the  plus 
ends of microtubules reorient toward the ring and activate   
myosin  II  contraction.  To  confirm  that  microtubule  plus 
ends abut where actin and myosin contract during both api-
cal and basal extrusion, we immunostained fixed, extrud-
ing  monolayers  for  EB1,  a  plus-end  microtubule-binding 
protein (Carvalho et al., 2003), myosin II, and DNA. Many 
EB1 spots localized to the basolateral surface during apical 
extrusion (Fig. 3 A, 3–6 µm from base), whereas far fewer   
EB1 spots localize to the apex during basal extrusion (Fig. 3 B, 
≥6 µm from the base). Quantification confirmed that more 
EB1 spots localized to the basolateral surface (0–4 µm from 
base) than the apical surface (4–8 µm from base) of the actin 
ring during apical extrusion compared with basal extrusion 
or to live cell–cell contacts, labeled “junction” (Fig. 3 C). 
These  experiments  suggest  that  microtubules  in  the  cells 
surrounding an apoptotic cell dynamically reorient toward 
the basolateral surface that contacts the dying cell during 
apical extrusion.
To test if microtubule reorientation toward the dying   
cell  is  required  for  basolateral  contraction  during  api-
cal  extrusion,  we  used  inhibitors  to  disrupt  microtubules 
and analyzed fixed, immunostained extruding monolayers. 
Destabilizing  microtubules  with  nocodazole  reduced  the 
number  of  apoptotic  cells  that  extruded  (no  contraction) 
and increased the percentage that extruded basally (Fig. 4,   
a and b). To block the reorientation of microtubules toward 
the basal surface during apical extrusion, we treated extrud-
ing monolayers with the microtubule-stabilizing drug taxol. 
Results and discussion
Using MDCK and 16-HBE-14o epithelial lines treated with 
UV
254 to induce apoptosis, we found that although most apop-
totic cells extrude apically, a small fraction extrudes basally. 
The direction of extrusion is apparent in the stills from phase 
videos (Fig. 1 and associated Videos 1–3). During apical ex-
trusion, the cell body is pushed out of the monolayer into the 
medium (Fig. 1 a and Video 1), whereas during basal extrusion, 
the cell becomes trapped between the monolayer and the cover 
glass and migrates underneath the monolayer (Fig. 1 b and   
Videos 2 and 3). Because epithelial monolayers in culture may 
have artificially strong adhesion to glass, we wanted to assess 
if similar ratios of apical versus basal extrusion also occurred 
in vivo. We have found that zebrafish larval epidermises pro-
vide an excellent model system to follow extrusion live, which 
can also be manipulated with inhibitors. G-418 treatment of   
4-d-old zebrafish larvae induces dying cells that predominantly 
extrude apically from the epidermis (Fig. 1 c and Video 4). 
Apically extruded cells exit into the fish water, whereas ba-
sally extruded cells become trapped beneath the epidermis 
(Fig. 1 d and Video 5).
We visually scored apical versus basal extrusion in UV-
treated, fixed monolayers (referred to as “extruding mono-
layers”) and zebrafish epidermises by assessing the location 
of  the  actin-extruding  ring  compared  with  the  extruded 
body, marked by compacted DNA and activated caspase-3 
staining (see Fig. 1, e and f for examples of apical and basal 
extrusion in MDCKs; and see Videos 6 and 7 and Fig. S2 for 
examples in zebrafish). During apical extrusion, the actin 
ring is thicker and extends to the base of the cell, whereas 
active caspase-3 and DNA (marking the extruded cell) are 
apical to the ring. In contrast, during basal extrusion, the 
actin ring is apical and similar in intensity to the cortical 
actin at adherens junctions in the live cells, and the caspase-3 
and DNA are basal to the contracted apical ring. Using these 
hallmarks for examining the polarity of extrusion, we found 
that zebrafish and tissue culture epithelia predominantly ex-
trude apoptotic cells apically. 89 ± 2.3% (SEM) from >500 
extruding cells (n = 4 experiments) from zebrafish epider-
mises, 80 ± 6% (SEM) of 1,250 extruding cells (n = 5 ex-
periments) from MDCK monolayers, and 79 ± 9% (SEM) of 
700 extruding cells (n = 7 experiments) from 16-HBE-14o 
monolayers extruded apoptotic cells apically; the remainder 
extruded basally.
What determines whether cells are extruded apically or 
basally? Two models for differentially regulating the direc-
tion are: (1) the intrinsic polarity of neighboring cells may 
be altered or lost, positioning cortical actin differentially; or 
(2) actin and myosin may be independently localized apically 
or basally. To examine if polarity was altered when cells ex-
truded apically versus basally, we immunostained extruding 
monolayers for the apical tight junction protein, ZO-1, and 
the basolateral adherens junction protein, -catenin (Yu et al., 
2005). ZO-1 remained apical and -catenin basal during either 
apical or basal extrusion (Fig. 2, a and b, respectively). The 
preserved localization of polarized adhesion markers suggests 695 POLARITY OF CELL EXTRUSION MECHANISM • Slattum et al.
dynamics shifted the balance of extrusions from apical to 
basal even more dramatically in zebrafish larval epidermises 
(from 89 ± 2.3% [SEM] to 27 ± 1.3% [SEM] in control vs. 
taxol treatments, from >900 extruding cells over four separate 
experiments, P < 0.0001). The drug treatments suggest that 
In contrast to control-treated cells, taxol treatment blocked 
microtubule reorientation toward the base of the dying cell 
(Fig. 4 a). Additionally, taxol treatment of monolayers shifted 
the  direction  of  extrusion  from  predominantly  apical  to   
basal (Fig. 4 b). We found that disruption of microtubule 
Figure 1.  Hallmarks of apical and basal apoptotic cell extrusion. Stills from phase videos of apoptotic cells extruding apically (a and c) and basally (b and d)   
in an MDCK cell culture epithelium (a and b) and from a zebrafish larval epidermis (c and d; teal arrows denote extruding cells). Time is given in hours 
and minutes. (e and f) An apoptotic cell extruding apically (e) and basally (f), immunostained for active caspase-3 (green), actin (red), and DNA (blue). 
Note that caspase and DNA are in the top z plane and a thick actin ring is in the bottom plane when a cell is extruded apically (e), whereas the actin ring 
is in the top plane and caspase and DNA are in bottom plane when extruding basally (f). Bars, 10 µm.JCB • VOLUME 186 • NUMBER 5 • 2009   696
basally, but if microtubules are allowed to reorient toward 
the base, contraction occurs along the basolateral surface, 
driving extrusion apically.
actin and myosin II contract at sites where microtubules con-
tact the cortex. When microtubules are frozen at the apex, 
actin/myosin  II  contract  at  the  apex  and  drive  extrusion   
Figure 2.  Localization of active myosin IIA but not intrinsic polarity markers are altered when cells are extruded apically or basally. (a and b) Cross sec-
tions of tight junction protein Z0-1 (a), which remains apical, and -catenin (b), which remains basal. (c) Myosin IIA and phospho-myosin II are basolateral 
during apical extrusion and apical during basal extrusion. Cross sections are taken from the broken line in pictures of 3D confocal reconstructions of MDCK 
cells. Arrows point to dying, extruded cells in each case. Bars, 10 µm.697 POLARITY OF CELL EXTRUSION MECHANISM • Slattum et al.
Because Rho activation in neighboring cells is required 
for extrusion contraction (Rosenblatt et al., 2001) and be-
cause microtubules can regulate several RhoGEFs (Krendel 
et al., 2002; Rogers et al., 2004), we hypothesized that micro-
tubules could regulate extrusion direction by locally activating 
Rho. Total RhoA protein localized throughout the live–dead 
cell interface, although myosin II contraction occurred only 
at the bottom of the actin/myosin ring during apical extru-
sion (Fig. 5 a, bottom), suggesting that Rho activation is re-
stricted to the basolateral surface. Because the Drosophila 
To determine if basolateral microtubule reorientation local-
izes myosin II or its activators to this surface, we immunostained 
extruding monolayers treated with nocodazole or taxol for myo-
sin II and phospho-myosin II. Both myosin II and phospho-myosin 
II localized to the extruding ring in control-treated monolayers 
but were substantially reduced in the presence of nocodazole, 
and restricted to the apex in the presence of taxol (Fig. S1). 
Disruption of both myosin II localization and activation with 
microtubule inhibitors suggests that microtubules promote both 
assembly and activation of the actin/myosin ring.
Figure 3.  The growing ends of microtubules point toward the actin/myosin ring during extrusion. (a and b) EB1 (green), a plus-end microtubule- 
binding protein, colocalizes with the myosin II (red) ring during apical (a) and basal (b) extrusion. Arrows point to sites where EB1 abuts the myosin II 
ring. Note that most EB1 is from 0–4 µm from the base during apical extrusion, whereas during basal extrusion, only limited amounts of EB1 are seen at 
the apex (6 µm from the base). Bars, 10 µm. (c) Quantification of EB1 localization (>170 spots for each) from 12 extrusions each of apically extruding 
cells, basally extruding cells, and live junctions. Error bars indicate SEM and P < 0.0001, comparing spots from apical extrusion to basal extrusion.JCB • VOLUME 186 • NUMBER 5 • 2009   698
RhoGEF siRNA had no effect on extrusion direction (Fig. 5 b). 
The percentage of cells that shifted from predominantly api-
cal to basal was similar to that seen with taxol treatment, 
which is consistent with p115 RhoGEF and microtubules acting 
in the same pathway.
Moreover, p115 RhoGEF, unlike RhoA, localizes only 
to sites of active myosin II contraction during both apical and 
basal extrusion. p115 RhoGEF appears in fibers that point to 
the base of the extruding ring during apical extrusion (Fig. 5 a, 
top; and Fig. 5 c). Unlike RhoGEF2 that localizes to micro-
tubule tips (Rogers et al., 2004), we found that p115 RhoGEF 
colocalizes along microtubules, suggesting that it either as-
sociates with microtubules or with a microtubule-associated 
RhoGEF2  associates  with  microtubule  plus  ends  to  drive 
Rho-mediated actin/myosin contraction during gastrulation   
(Rogers et al., 2004), we investigated whether members of the 
regulator of G protein signaling (RGS) family of RhoGEFs, 
mammalian homologues of RhoGEF2 (Fukuhara et al., 2001),   
were required for apical extrusion. We treated 16-HBE-14o 
monolayers with siRNAs directed against PDZ RhoGEF, p115 
RhoGEF, and leukemia-associated RhoGEF (LARG), and as-
sayed the direction of extrusion in the resulting monolayers. 
Knockdown of PDZ and LARG RhoGEFs had no obvious 
effect on extrusion direction (Fig. S3, a and b). However, 
knockdown of p115 RhoGEF dramatically reduced the per-
centage of apically extruding cells, whereas scrambled p115 
Figure 4.  Disruption of microtubules alters the direction a cell extrudes. (a) In control (DMSO-treated) MDCK monolayers, microtubules dip down toward 
the basolateral surface of the actin ring, whereas nocodazole either blocks contraction of the ring (as shown) or drives extrusion basally. Stabilizing micro-
tubules with taxol freezes microtubules at the apex compared with control and drives extrusion basally. Broken lines indicate the site of cross sections from 3D 
confocal reconstructions above. Bars, 10 µm. (b) Quantification of drug-treatments from six experiments, n = 1,350 extruding cells per treatment. P-values 
for apical and basal extrusions, respectively, were 0.0011 and 0.0066 for nocodazole and 0.0023 and 0.0023 for taxol. Error bars indicate SEM.699 POLARITY OF CELL EXTRUSION MECHANISM • Slattum et al.
Figure 5.  p115 RhoGEF is required for apical extrusion. (a) p115 RhoGEF (red; separate middle panel) form filaments that point toward the basolateral 
surface of the extruding ring during apical extrusion, whereas RhoA (green; bottom panel) is present through the apical and basal regions of the ring. Cor-
responding colored arrows indicate sites of interaction with the actin/myosin ring. Bar, 10 µm. (b) siRNA-mediated knockdown of p115 RhoGEF (above, 
lanes from one immunoblot) disrupts apical extrusion, whereas scrambled siRNA does not. The graph shows the percentage of apical versus basal extrusion 
from >1,000 cells from four siRNAs experiments, where P < 0.0001. (c) p115 RhoGEF localizes to the base of the extruding ring during apical extru-
sion, whereas it does not when microtubules are disrupted with nocodazole or taxol, or in control live junctions, where P-values are <0.0001 for control 
versus each treatment; n = 10 extrusions per treatment. (d) Model for how microtubules might control extrusion direction. An early apoptotic cell sends 
signals to its live neighboring epithelial cells, which react by reorienting microtubules toward the basolateral surfaces of the cells that contact the dying 
cell. p115 RhoGEF, by association with microtubules, assembles and activates Rho-mediated actin and myosin II contraction along the basolateral surface, 
extruding the cell apically (top). Basal extrusion occurs if the microtubules do not reorient or if p115 RhoGEF is absent (bottom).JCB • VOLUME 186 • NUMBER 5 • 2009   700
death with a caspase inhibitor does not block cell extrusion 
(Rosenblatt et al., 2001). Further, many high-grade epithelial 
tumors have mutations in apoptosis (Yang et al., 2003; Schulze-
Bergkamen and Krammer, 2004; Meulmeester and Jochemsen, 
2008) that would block apoptosis at steps we predict would not 
block extrusion.
In situations where cells can extrude without dying, the 
direction a cell extrudes is pivotal for its fate. In cancer, apical 
extrusion could act as a tumor suppressor, eliminating tumor 
cells through the lumen. Even in cases where tumors cells accu-
mulate in a closed lumen, such as in breast ductal carcinoma in 
situ, they rarely invade and metastasize (Kopans et al., 2003). 
Basal extrusion, however, could provide an exit path for these 
tumor cells to initiate metastasis and migrate to other sites in the 
body. Evidence for basal extrusion promoting invasion exists in 
Drosophila larvae and pupae when cell death is blocked, as   
extrusion in these tissues occurs almost exclusively basally   
(Pagliarini and Xu, 2003; Gibson and Perrimon, 2005; Thompson 
et al., 2005; Vidal et al., 2006; Ninov et al., 2007; Hogan et al., 
2009). Further work will test if basal extrusion of tumor 
cells could enable their invasion and metastasis through the 
matrix and into the bloodstream in vertebrates. Our results iden-
tifying a role for microtubules in regulating the direction of 
extrusion in zebrafish will allow us to follow the fate of basally 
extruded live cells in a vertebrate model where single cells can 
be readily imaged and tracked (Redd et al., 2006).
Materials and methods
Cell culture
MDCK II cells (gift from K. Matlin, University of Chicago, Chicago, IL) were 
cultured in Dulbecco’s minimum essential medium (DMEM) high glucose 
with 5% FBS and 100 µg/ml penicillin/streptomycin (all from Invitrogen) at 
5% CO2, 37°C. 16-HBE-14o (provided by D. Gruenert [California Pacific 
Medical Center, San Francisco, CA] and J. Porter [University College Lon-
don, London, England, UK]) were cultured in MEM containing Earle’s salts,   
1  g/liter  glucose,  2.2  g/liter  NaHCO3,  l-glutamine,  10%  FBS,  and   
100 µg/ml penicillin-streptomycin (Invitrogen) in a flask coated with human 
fibronectin type I (BD), bovine collagen I (Purecol; Inamed biomaterials), and 
BSA (Invitrogen) at 5% CO2, 37°C.
Transfections
siRNAs  were  synthesized  at  the  University  of  Utah  oligo  and  peptide 
synthesis core to the following sequences: p115 RhoGEF (5-GCAGCU-
CUGAGAACGGCAA-3),  LARG  RhoGEF  (5-GAAACUCGUCGCAU-
CUUCC-3), PDZ RhoGEF (5-ACUGAAGUCUCGGCCAGCU-3), and 
scrambled control siRNA (5-UUCUCCGAACGUGUCACGU-3). Antisense 
and sense duplexes LARG RhoGEF and P115 RhoGEF were annealed in   
100 mM potassium acetate, 30 mM Hepes-KOH, 2 mM magnesium acetate,   
pH 7.4, and PDZ RhoGEF duplexes in 50 mM Tris, pH 8.0, and 100 mM 
NaCl at 90°C for 1 min and 37°C for 1 h. 50 pMol (LARG and P115) or 
30 pMol (PDZ) siRNAs were transfected by nucleofection using the solution   
V-program G016 (Amaxa) or by RNAimax Reverse Transfection according to 
the manufacturer’s instructions (Invitrogen). We also confirmed our results 
using two independent shRNAs directed against p115, PDZ, and LARG 
RhoGEFs (gift from A. Jaffe [Novartis, Boston, MA] and A. Hall [Memorial 
Sloan Kettering Cancer Center, New York, NY]).
Cell staining
For EB1 and myosin IIA staining, cells were fixed with 100% methanol 
at 20°C for 45 s. For RhoGEF p115 staining, monolayers were pre-
permeablized with PBS with 0.1% Triton X-100 containing 1 µg/ml phal-
loidin for 60 s before fixation with 4% formaldehyde in PBS at 37°C 
for 20 min. For all other immunostainings, cells were fixed with 4% 
formaldehyde in PBS at 37°C for 20 min. Fixed cells were rinsed three 
times in PBS, permeabilized for 5 min with PBS containing 0.5% Triton 
matrix (Fig. S3 c). To test if p115 RhoGEF localization was 
dependent on microtubules, we quantified the number of p115 
RhoGEF fibers in control-extruding monolayers compared with 
nocodazole or taxol-treated monolayers. Compared with control-
treated monolayers, taxol treatment restricted p115 RhoGEF 
to the apex (Figs. 5 c and S3 d, for a representative picture), 
whereas nocodazole treatment eliminated p115 RhoGEF at   
the dying cell, similar to levels seen at live cell–cell junctions 
(Figs. 5 c and S3 e). These results suggest that microtubules 
localize p115 RhoGEF to activate basolateral contraction dur-
ing apical extrusion. Although Rho exists throughout the ring, 
and microtubules and p115 span the extruding live cells, Rho is 
activated only at sites where it intersects with p115 RhoGEF.
Based on the effects of disrupting microtubules and p115 
RhoGEF on the direction of extrusion, we propose a model for 
how microtubules control the direction of extrusion (Fig. 5 d). 
When cells are extruded apically (Fig. 5 d, top), the cells sur-
rounding a cell destined to die reorient their microtubules to-
ward the basolateral surfaces that interface with the dying cell. 
Microtubules target p115 RhoGEF to the basolateral surface, 
where it activates Rho, present at the live–dead cell interface, to 
assemble and activate myosin IIA contraction. The extrusion 
ring contracts circumferentially around the dying cell as well as 
basolaterally to squeeze the apoptotic cell out apically. Failure 
of p115 RhoGEF to target to the basolateral surface, either by 
its knockdown or by disruption of microtubule reorientation, 
results in basal extrusion (Fig. 5 d, bottom). Here, actin and 
myosin IIA already present at apical adherens junctions could 
readily contract circumferentially around the dying cell. How-
ever,  because  basolateral  actin/myosin  contraction  is  absent, 
contraction is restricted to the apex, forcing the apoptotic cell 
out basally. During both types of extrusion, adherens and tight 
junctions are maintained above the sites of contraction, which 
preserves the barrier function of the epithelium throughout the 
extrusion process (as seen in Fig. 2, a and b).
Although we have found that microtubule reorientation is 
important for apical extrusion, microtubule disruption did not re-
verse the extrusion direction in 100% of cells, which suggests 
that other factors may also contribute to extrusion polarity. The 
extrusion polarity effects from taxol treatment were more dra-
matic in zebrafish than in culture, which suggests that this deci-
sion is regulated more tightly in vivo. Other factors affecting 
extrusion polarity may include matrix, intrinsic polarity, or cell 
height. A more adhesive surface may encourage apical extrusion, 
whereas basal extrusion might dominate in monolayers on a less 
adhesive substratum. Taller epithelia, such as in the gut, would 
likely show more dramatic effects in extrusion polarity than 
would flatter epithelia.
Several observations suggest that extrusion may not be 
limited to apoptotic cells, but could be a common mechanism 
for living cells to exit an epithelium without disrupting epithe-
lial function. Apoptotic extrusion looks morphologically similar 
to developmental events where single cells exit the epithelium, 
such as neuroblast delamination in Drosophila melanogaster 
(Hartenstein et al., 1994). Here, cells exit the neuroepithelium 
and, instead of dying, divide asymmetrically before differentiat-
ing into neurons. We have previously found that blocking cell 701 POLARITY OF CELL EXTRUSION MECHANISM • Slattum et al.
in 12 randomly selected cell extrusions (>170 z sections). The number of 
EB1 spots at the base was averaged from the bottom 12 of 24 z sections 
and at the apex from the top 12 of 24 z sections, where the error bars 
indicate SEM from the variation of 12 separate apical and basal extru-
sions, and 12 cell–cell contacts where p-values from a t test are <0.0001 
for apical versus basal extrusion. For quantification of p115 RhoGEF fibers 
intersecting with the extruding ring, we created montages (as described in 
the image acquisition section) and manually counted the number of p115 
RhoGEF spots abutting the extrusion ring in the first 0–4 µm (base) and the 
next 4–8 µm (apex) from the bottom of the cell. Statistical analysis was 
done on 10 separate extrusions from control, nocodazole, taxol, and junc-
tions from each, where error bars represent the SEM and the p-values from 
a t test are <0.0001 for each compared with the control.
Online supplemental material
Fig. S1 shows that disruption of microtubules mislocalizes myosin IIA and 
phospho-myosin II in 16-HBE-14o cell monolayers. Fig. S2 shows that taxol 
treatment induces basal extrusion in zebrafish larval epidermis. Fig. S3 
shows that siRNA-mediated knockdown of other RGS-RhoGEFs has no 
effect on the direction of extrusion, and that disruption of microtubules dis-
rupts localization of RhoGEF p115. Videos 1–3 show typical basal and 
apical extrusion from MDCK cell monolayers. Videos 4–7 shows apical 
and basal extrusion from the epidermis of 4-d-old zebrafish. Videos 8–9 
show apical and basal extrusion, respectively, in MDCK cells expressing 
mApple-actin and GFP-tubulin. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200903079/DC1.
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